Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2872033

CCCCCCCC/C=C\CCCCCCCCOCC[N+](C)(C)CCOCCCCCCCC/C=C\CCCCCCCC.[Cl-]

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 1/20 0.45
LPAR2 Q9HBW0 1/20 0.45
LPAR3 Q9UBY5 1/20 0.45
HTT P42858 1/20 0.43
PRKD3 O94806 1/20 0.42
PRKCG P05129 1/20 0.42
PRKCB P05771 1/20 0.42
PRKCA P17252 1/20 0.42
PRKCH P24723 1/20 0.42
PRKCI P41743 1/20 0.42
PRKCE Q02156 1/20 0.42
PRKCQ Q04759 1/20 0.42
PRKCZ Q05513 1/20 0.42
PRKCD Q05655 1/20 0.42
PRKD1 Q15139 1/20 0.42
FAAH O00519 2/20 0.42
TRPV1 Q8NER1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2872041 1.00 LPAR1 (0.45) LPAR1LPAR2LPAR3HTTPRKD3
SCHEMBL6944334 0.98 LPAR1 (0.46) LPAR1LPAR2LPAR3HTTPRKD3
SCHEMBL6944331 0.98 LPAR1 (0.46) LPAR1LPAR2LPAR3HTTPRKD3
Hydrochloric Acid SCHEMBL30621326 0.97 HTT (0.50) HTT
Hydrochloric Acid SCHEMBL2870004 0.89 LPAR1 (0.45) LPAR1LPAR2LPAR3PRKD3PRKCG
Hydrochloric Acid SCHEMBL2870007 0.89 LPAR1 (0.45) LPAR1LPAR2LPAR3PRKD3PRKCG
Hydrochloric Acid SCHEMBL2912559 0.89 HTT (0.54) HTTPRKD3PRKCGPRKCBPRKCA
SCHEMBL9129466 0.87 PRKD3 (0.56) LPAR1LPAR2LPAR3PRKD3PRKCG
SCHEMBL9129474 0.87 PRKD3 (0.56) LPAR1LPAR2LPAR3PRKD3PRKCG
Hydrochloric Acid SCHEMBL45755 0.87 HTT (0.50) HTTPRKD3PRKCGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229162-A1 LAUNDRY CARE ADDITIVE PARTICLES The Procter & Gamble Company (US) 2023-08-23 EP disclosed
WO-2023107847-A1 USE OF A FABRIC SOFTENING COMPOSITION TO REDUCE AIRBORNE FIBRES RELEASE FROM A DRYER THE PROCTER & GAMBLE COMPANY (US) 2023-06-15 WO disclosed
EP-4146471-A1 MULTI-LAYER DRYER SHEET The Procter & Gamble Company (US) 2023-03-15 EP disclosed
WO-2022182633-A1 METHOD FOR TREATING A FABRIC IN A DRYER IN PRESENCE OF MICROORGANISMS THE PROCTER & GAMBLE COMPANY (US) 2022-09-01 WO disclosed
WO-2022081782-A1 LAUNDRY CARE ADDITIVE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2022-04-21 WO disclosed
EP-2567951-B1 CATIONIC LIPID KYOWA HAKKO KIRIN CO LTD (JP) 2018-09-19 EP disclosed
EP-3301086-A1 PRODUCTION OF A COMPOSITION CONTAINING A COMPLEX BETWEEN A MEMBRANE COMPOSED OF A LIPID MONOLAYER AND A NUCLEIC ACID, AND, A LIPID MEMBRANE FOR ENCAPSULATING THE COMPLEX THEREIN Kyowa Hakko Kirin Co., Ltd. (JP) 2018-04-04 EP disclosed
US-9920028-B2 Cationic lipid KYOWA HAKKO KIRIN CO., LTD. (JP) 2018-03-20 US disclosed
US-9845306-B2 Cationic lipid KYOWA HAKKO KIRIN CO., LTD. (JP) 2017-12-19 US disclosed
US-20170349532-A1 CATIONIC LIPID KYOWA HAKKO KIRIN CO., LTD. (JP) 2017-12-07 US disclosed
US-20130280305-A1 CATIONIC LIPID KYOWA HAKKO KIRIN CO., LTD. (JP) 2013-10-24 US disclosed
US-20130108685-A1 CATIONIC LIPID KYOWA KIRIN CO., LTD. (JP) 2013-05-02 US disclosed
EP-2567951-A1 CATIONIC LIPID Kyowa Hakko Kirin Co., Ltd. (JP) 2013-03-13 EP disclosed
US-7659239-B2 incorporating friable perfume microcapsules into dryer-added articles that maximizes the yield of unruptured microcapsules; consumers have freshness experience while wearing clothing treated therewith THE PROCTER & GAMBLE COMPANY (US) 2010-02-09 US disclosed
EP-1106676-B1 Method for providing in-wear comfort PROCTER & GAMBLE (US) 2005-04-06 EP disclosed
US-20030216094-A1 Method for providing in-wear comfort PROCTER & GAMBLE COMPANY, THE 2003-11-20 US disclosed
EP-1230332-A1 FABRIC ENHANCEMENT TREATMENT THE PROCTER & GAMBLE COMPANY (US) 2002-08-14 EP disclosed
WO-2001042412-A1 METHOD FOR PROVIDING IN-WEAR COMFORT THE PROCTER & GAMBLE COMPANY (US) 2001-06-14 WO disclosed
EP-1106676-A1 Method for providing in-wear comfort THE PROCTER & GAMBLE COMPANY (US) 2001-06-13 EP disclosed
WO-2001036575-A1 FABRIC ENHANCEMENT TREATMENT THE PROCTER & GAMBLE COMPANY (US) 2001-05-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349532-A1 CATIONIC LIPID LPAR3, ACOX3, H1-3 LPAR1 6/4885LPAR2 8/4885LPAR3 1/4885
US-20130108685-A1 CATIONIC LIPID LPAR3, ACOX3, H1-3 LPAR1 6/4885LPAR2 8/4885LPAR3 1/4885
US-20130280305-A1 CATIONIC LIPID LPAR3, ACOX3, H1-3 LPAR1 6/4885LPAR2 8/4885LPAR3 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.